Oncolytics Logo
  • About Us
    • Our Company
    • Leadership Team
  • REOLYSIN®
    • What is REOLYSIN®?
    • Clinical Trials
    • Intellectual Property
    • Papers & Presentations
  • Investor Center
    • Investor Overview
    • Stock Information
    • Financials
    • Presentations
    • Corporate Governance
    • RSS Feeds
    • Analyst Coverage
  • News
  • Contact

Investor Center
Presentations

  • Investor Center
  • Presentations

Slide Shows & Poster Presentations

Date Description
2017-08-08 Canaccord Annual Growth Conference
2017-08-08 August 2017 Corporate Presentation
2017-05-04 2017 Annual General Meeting of Shareholders
2017-05-02 Bloom Burton & Co. Healthcare Investor Conference

Investor Center

  • Investor Overview
  • Stock Information
  • Financials
  • Presentations
  • Corporate Governance
  • RSS Feeds
  • Analyst Coverage
  • News
Dec 27, 2017

Oncolytics Biotech® Announces Poster Presentation at the 2018 Gastrointestinal Cancers Symposium Sponsored by ASCO in Patients with Relapsed Metastatic Adenocarcinoma of the Pancreas Read More

Dec 5, 2017

Oncolytics Biotech® Receives Favorable Final Advice Letter from the European Medicines Agency for REOLYSIN® in Metastatic Breast Cancer Read More

View all news articles
Aug 9, 2016

Exploring REOLYSIN®’s Objective Response Rate in Females with Colorectal Cancer Read More

Exploring REOLYSIN<sup>®</sup>’s Objective Response Rate in Females with Colorectal Cancer thumbail
View all blog posts

LATEST TWEETS

@Oncolytics Feb 23, 2021

Data from a Mayo study show pelareorep demonstrated the potential to broaden the applicability of CAR T cells to so… https://t.co/ausWexcm4f

@Oncolytics Feb 4, 2021

Learn how pelareorep works with immunotherapies in this brief clip, a full length version of this video can be foun… https://t.co/UqCHYemBKi

Follow us on Twitter
  • About Us
    • Our Company
    • Leadership Team
  • REOLYSIN®
    • What is REOLYSIN®?
    • Clinical Trials
    • Intellectual Property
    • Papers & Presentations
  • Investor Center
    • Investor Overview
    • Stock Information
    • Financials
    • Presentations
    • Corporate Governance
    • RSS Feeds
    • Analyst Coverage
  • News
  • Contact

Sign up to receive email updates

Sign Up
Linkedin Icon
  • Privacy | Legal Notice
Copyright © Oncolytics Biotech® Inc. 2021 All rights reserved

Site by
Site by Pace Creative Alberta Site by Pace Creative Alberta